Lantern Pharma Inc.
LTRN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $8 | $22 | $37 | $52 |
| Short-Term Investments | $17 | $19 | $18 | $19 |
| Receivables | $0 | $1 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $4 | $2 |
| Total Curr. Assets | $25 | $43 | $59 | $73 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $1 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $26 | $44 | $59 | $74 |
| Liabilities | – | – | – | – |
| Payables | $0 | $1 | $0 | $2 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4 | $2 | $3 | $0 |
| Total Curr. Liab. | $4 | $3 | $3 | $2 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $4 | $3 | $3 | $2 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$76 | -$55 | -$39 | -$25 |
| AOCI | $0 | -$0 | -$0 | -$0 |
| Other Equity | $97 | $96 | $96 | $97 |
| Total Equity | $21 | $41 | $56 | $72 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $26 | $44 | $59 | $74 |
| Net Debt | -$7 | -$22 | -$37 | -$51 |